ACS Chem Biol. 2011 Nov 18;6(11):1188-92. doi: 10.1021/cb200277u. Epub 2011 Sep 22.
The intrinsic stabilization of therapeutic proteins by N-glycosylation can endow them with increased shelf and serum half-lives owing to lower populations of misfolded and unfolded states, which are susceptible to aggregation and proteolysis. Conjugation of poly(ethylene glycol) (PEG) oligomers to nucleophilic groups on the surfaces of folded proteins (i.e., PEGylation) is a chemical alternative to N-glycosylation, in that it can also enhance the pharmacologic attributes of therapeutic proteins. However, the energetic consequences of PEGylation are currently not predictable. We find that PEGylation of an Asn residue in reverse turn 1 of the Pin WW domain is intrinsically stabilizing in several sequence contexts, unlike N-glycosylation, which is only stabilizing in a particular sequence context. Our thermodynamic data are consistent with the hypothesis that PEGylation destabilizes the protein denatured state ensemble via an excluded volume effect, whereas N-glycosylation-associated stabilization results primarily from native state interactions between the N-glycan and the protein.
N-糖基化可使治疗性蛋白内在稳定化,从而增加其货架期和血清半衰期,因为其错误折叠和未折叠状态的比例较低,这些状态易发生聚集和蛋白水解。聚乙二醇(PEG)低聚物与折叠蛋白表面的亲核基团(即 PEG 化)的缀合是 N-糖基化的化学替代方法,因为它也可以增强治疗性蛋白的药理特性。然而,PEG 化的能量后果目前是不可预测的。我们发现,在几种序列环境中,Pin WW 结构域中反环 1 上的 Asn 残基的 PEG 化在本质上是稳定的,与 N-糖基化不同,N-糖基化仅在特定的序列环境中稳定。我们的热力学数据与以下假设一致,即 PEG 化通过排除体积效应使蛋白质变性状态的集合不稳定,而 N-糖基化相关的稳定性主要来自 N-聚糖与蛋白质之间的天然状态相互作用。